Welcome to MS Australia
News
The Pharmaceutical Benefits Advisory Committee (PBAC) announced at 4pm today (20/4/18), they have not recommended the listing of MAVENCLAD® (cladribine tablets) for relapsing remitting MS (RRMS) on the Pharmaceutical Benefits Scheme (PBS).
The PBAC said that it, “did not recommend the listing of cladribine for the treatment of relapsing remitting multiple sclerosis (RRMS), on the basis of uncertainty in the non-inferior efficacy claim...
Blog
Unlike most diagnoses of Multiple Sclerosis 24 hours was all it took to receive my diagnosis and, what's more, it was me that asked to be tested specifically for MSIt was November 1997 when I went off to see a neurologist. I had been booked in to see the specialist following a car accident with a semi-trailer which resulted in me suffering whiplash. "Whilst I am here,” I said to the specialist, “can you also test me for Multiple Sclerosis?" With that he frowned at me and asked me why I thought...
Events
Tweets by @MS_Australia
Tweets by MS_AustraliaSupport & Services
As the national peak body for Australians living with MS, we work closely with the state MS societies to help you connect with the right support and services.